Immucell Corp
ICCC- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000811641
No open-market purchases or sales by Immucell Corp insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.4M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Immucell Corp changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 28 | 29 | +1 |
| Shares | 862.8K | 880.2K | +17.4K (+2.0%) |
| Value | $8.05M | $7.04M | −$1.01M (−12.5%) |
New holders (3)
Institutions that held Immucell Corp at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wealth Effects LLC | 15,850 | $127.0K | 0.05% |
| Total Clarity Wealth Management, Inc. | 648 | $5.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 100 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Immucell Corp at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| O'Shaughnessy Asset Management, LLC | 1,443 | $14.0K |
| Harbour Investments, Inc. | 250 | $2.00K |